Back to top
more

iShares Nasdaq Biotechnology Index Fund: (IBB)

(NA) As of Apr 24, 2017 03:59 PM ET

 Add to portfolio

$291.74 USD

291.74
914,173

+4.25 (1.48%)

Volume: 914,173

Zacks ETF Rank 3 - Hold     3    

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 287.49
Open 290.64
Bid 291.12
Ask 291.88
Day Low-High 289.83-292.40
52wk Low-High 240.30-303.74
Volume 914,173
NAV (month end) 8.16
Premium (+)/Discount (-) (month end)+279.33

Zacks Premium Research for IBB

Zacks ETF Rank Hold 3
ETF Risk High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.47%
Dividend (Yield) $0.64 (0.22%)
Issuer BLACKROCK

Benchmark for IBB

NASDAQ BIOTECHNOLOGY INDEX

The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceuticals.

Fund Summary for IBB

ISHARES NASDAQ BIOTECHNOLOGY ETF

The iShares Nasdaq Biotechnology ETF seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.